Medicare Enrolled

Dr. Armen Derboghossians, M.D

Urology Physician · Glendale, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
116 S LOUISE ST, Glendale, CA 91205
8185074340
In practice since 2011 (14 years)
NPI: 1558641852 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Derboghossians from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Derboghossians? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Derboghossians

Dr. Armen Derboghossians is an urology physician in Glendale, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Derboghossians performed 3,691 Medicare services across 3,030 unique beneficiaries.

Between the years covered by Open Payments, Dr. Derboghossians received a total of $2,050 from 14 pharmaceutical and/or device companies across 89 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Derboghossians is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ Top 23% volume in CA $2,050 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,691
Medicare services
Top 23% in CA for urology physician
3,030
Unique beneficiaries
$132
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~264 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
761 $76 $180
Complete pelvic ultrasound
An imaging test using sound waves to create pictures of the organs and structures within the pelvis.
708 $96 $350
Leuprolide acetate (for depot suspension), 7.5 mg 416 $136 $814
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
330 $210 $500
Complex urodynamic pressure measurement
A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures.
257 $349 $602
Abdominal device insertion with pressure and urine flow study
A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate.
256 $178 $350
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
254 $28 $319
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
232 $141 $250
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
199 $95 $201
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
89 $31 $100
Urethral dilation using endoscope
A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage.
58 $294 $795
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
48 $100 $350
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
28 $208 $450
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
28 $52 $400
Bladder tumor removal via endoscope
This procedure involves using an endoscope to destroy or remove a large growth from the bladder.
15 $321 $1,100
Shock wave crushing of kidney stones
A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body.
12 $481 $1,600
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,050
Total received (2018-2024)
Avg $293/year across 7 years
Bottom 46% in CA for urology physician
14
Companies
89
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,738 (84.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$312 (15.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$414
2023
$197
2022
$363
2021
$150
2020
$195
2019
$292
2018
$438

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$343
PROCEPT BioRobotics Corporation
$39
Astellas Pharma US Inc
$32
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,085
Sumitomo Pharma America, Inc.
$343
PFIZER INC.
$163
Janssen Biotech, Inc.
$130
AbbVie Inc.
$71
Teleflex LLC
$46
TOLMAR Pharmaceuticals, Inc.
$40
PROCEPT BioRobotics Corporation
$39
Boston Scientific Corporation
$33
Medtronic USA, Inc.
$26
ABBVIE INC.
$23
AbbVie, Inc.
$22
Merck Sharp & Dohme Corporation
$18
Mallinckrodt Enterprises LLC
$12
Top 3 companies account for 77.6% of all-time payments
Associated products mentioned in payments ›
AQUABEAM SYSTEM · BRIDION · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL BPH · INTERSTIM · LUPRON DEPOT · Lupron Depot · MYRBETRIQ · Myrbetriq · OFIRMEV · TOVIAZ · UroLift System · Veozah · XTANDI · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (85%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Glendale?
Compare urology physicians in the Glendale area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
389
Per 100K population
3.9
County median income
$87,760
Nearest hospital
GLENDALE MEM HOSPITAL & HLTH CENTER
0.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Derboghossians is a clinical cardiology specialist, with above-average Medicare volume (top 23% in CA), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Derboghossians experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Derboghossians performed 761 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Derboghossians receive payments from pharmaceutical companies?
Yes. Dr. Derboghossians received a total of $2,050 from 14 companies across 89 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Derboghossians's costs compare to other urology physicians in Glendale?
Dr. Derboghossians's average Medicare payment per service is $132. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Derboghossians) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →